M90.60 Osteitis deformans in neoplastic diseases, unspecified site

Name of the Condition

• Osteitis deformans in neoplastic diseases, unspecified site

Summary

Osteitis deformans in neoplastic diseases, unspecified site (ICD Code M90.60) refers to a bone disorder characterized by abnormal bone remodeling, occurring as a secondary manifestation of neoplastic (cancerous) diseases. This condition involves structural changes in bone tissue due to the underlying malignancy, which disrupts normal bone metabolism and can lead to deformities or other complications.

Causes

The primary cause is the presence of neoplastic diseases, such as primary bone tumors or metastatic cancer, which affect bone tissue. These malignancies can stimulate abnormal bone formation or resorption, leading to the characteristic changes of osteitis deformans. The underlying cancer drives the bone pathology.

Risk Factors

• Malignancies (primary or metastatic) involving bone
• Advanced-stage cancers with bone involvement
• Certain hematologic malignancies (e.g., multiple myeloma)
• Prolonged exposure to cancer-related bone microenvironment changes

Symptoms

• Bone pain or tenderness
• Skeletal deformities (e.g., bowing of long bones)
• Increased risk of fractures
• Joint stiffness or swelling
• Reduced mobility or function

Diagnosis

Diagnosis involves correlating clinical findings with the underlying neoplastic disease. Imaging (X-rays, MRI, or CT) assesses bone changes, while lab tests or biopsy confirm the presence of cancer. Bone scans or PET scans may help identify affected sites. Documentation of the associated neoplasm is essential for accurate coding.

Treatment Options

• Management of the underlying neoplastic disease (e.g., chemotherapy, radiation)
• Pain management (e.g., analgesics, bisphosphonates)
• Orthopedic interventions for deformities or fractures
• Physical therapy to maintain mobility

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying neoplasm. Regular monitoring of bone health and cancer progression is critical. Follow-up may include imaging, lab tests, and assessments for complications like fractures or deformities.

Complications

• Pathologic fractures
• Severe bone deformities
• Chronic pain
• Reduced quality of life due to mobility limitations

Lifestyle & Prevention

• Maintain bone health through adequate nutrition (calcium, vitamin D)
• Avoid activities that increase fracture risk
• Follow cancer treatment plans to manage underlying disease
• Engage in gentle exercise to preserve mobility

When to Seek Professional Help

Seek medical attention for persistent bone pain, new deformities, or fractures. Prompt evaluation is necessary if symptoms worsen or interfere with daily activities.

Tips for Medical Coders

Document the associated neoplastic disease and specify the bone site if known. For unspecified site, use M90.60. Ensure clinical correlation between the neoplasm and bone changes to support accurate coding.